findmyKOL

Yaron Fridman, MD

Basic profile

Asheville Cardiology Associates

ORCIDNone on fileNPI
RegionAsheville, NC · SoutheastSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Yaron Fridman is a Cardiology physician affiliated with Asheville Cardiology Associates. OpenAlex indexes 19 publications with 889 citations (h-index 11).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
19publications

Distinct works indexed by OpenAlex.

889citations

Total citations across indexed works.

11h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

509 Biltmore Ave
Asheville, NC 288014601

Telephone

828-213-0152

Registry record last updated 4 Jan 2022.

View the NPPES registry record

Industry payments

4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    82%
    Beta blocker23.6%
    Metoprolol Succinate50%Carvedilol31%Metoprolol Tartrate14%Propranolol Hcl Er2%Atenolol2%Sotalol2%
    Part D<11 patients
    Statin15.1%
    Atorvastatin Calcium60%Rosuvastatin Calcium31%Pravastatin Sodium9%
    Part D89 patients

    + 14 more classes in this area

  • Blood & clotting

    15%
    Factor Xa inhibitor12%
    Eliquis77%Xarelto24%
    Part D72 patients
    P2Y12 inhibitor3.1%
    Clopidogrel100%
    Part D29 patients
  • Metabolism & gastrointestinal

    2.9%
    SGLT2 inhibitor2.1%
    Jardiance68%Farxiga32%
    Part D<11 patients
    Potassium supplement0.5%
    Potassium Chloride100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)73.4% facility · 26.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”